S81378 |
GSK481 |
源葉(MedMol) | 98% |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.65 ml | 13.249 ml | 26.498 ml |
5 mM | 0.53 ml | 2.65 ml | 5.3 ml |
10 mM | 0.265 ml | 1.325 ml | 2.65 ml |
50 mM | 0.053 ml | 0.265 ml | 0.53 ml |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述: GSK481 is a highly potent, selective, and specific receptor interacting protein 1 (RIP1) kinase inhibitor with an IC50 of 1.3 nM, which inhibits Ser166 phosphorylation in wild-type human RIP1 (IC50=2.8 nM). GSK481 also exhibits excellent translation in the U937 cellular assay with an IC50 of 10 nM
- 靶點: IC50: 1.3 nM (RIP1), 2.8 nM (Ser166 phosphorylation in wild-type human RIP1);RIPkinase
- 體外研究:
GSK481 (300 nM; 2 hours; Jurkat cells) abrogates the RIP3 up-regulation induces by both TNFa and shikonin in live and dead cells, indicating that necroptosis is in fact induced by both agents. Apoptosis Analysis Cell Line: Jurkat cells Concentration: 300 nM Incubation Time: 2 hours Result: Increased levels of detectable apoptosis induced by TNFa and shikonin.
- 體內(nèi)研究:
GSK481 inhibits Ser166 phosphorylation in three mouse RIP1 mutants (IC50=18~110 nM) more potently than in wild-type mouse
- 參考文獻(xiàn):
1. Harris PA et al. DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. J Med Chem, 2016 Mar 10, 59(5):2163-78. 2. Lee HL, et al. Simultaneous flow cytometric immunophenotyping of necroptosis, apoptosis and RIP1-dependent apoptosis. Methods. 2018 Feb 1;134-135:56-66.
- 溶解性: soluble in DMSO
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.65 ml 13.249 ml 26.498 ml 5 mM 0.53 ml 2.65 ml 5.3 ml 10 mM 0.265 ml 1.325 ml 2.65 ml 50 mM 0.053 ml 0.265 ml 0.53 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)